Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05445869 · ClinicalTrials.gov registry record · NA
Severe OSA Study (SOS)
A NA study, sponsored by ProSomnus Sleep Technologies.
- Terminated
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT05445869 is a NA study that was terminated before completion, run by ProSomnus Sleep Technologies. The registered enrollment target is 35 participants.
The verdict
NCT05445869, a NA study, was terminated before completion, sponsored by ProSomnus Sleep Technologies.
- TERMINATED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
This study is a prospective, multi-center, single-arm, open-label study evaluating the safety and effectiveness of therapy with the ProSomnus EVO Sleep and Snore Device in individuals with severe obstructive sleep apnea.
Interventions
- DEVICE ProSomnus® EVO Sleep and Snore Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2022-09-12 |
| Est. Completion | 2024-02-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05445869
The ClinicalTrials.gov registry entry for NCT05445869 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ProSomnus Sleep Technologies, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ProSomnus® EVO Sleep and Snore Device is the first listed.
NCT05445869 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05445869 about?
NCT05445869 is a clinical study titled "Severe OSA Study (SOS)". This study is a prospective, multi-center, single-arm, open-label study evaluating the safety and effectiveness of therapy with the ProSomnus EVO Sleep and Snore Device in individuals with severe obstructive sleep apnea.
What is the current status of trial NCT05445869?
This trial is currently terminated. It is a NA study. The enrollment target is 35 participants. The study started on 2022-09-12. Estimated completion is 2024-02-15.
What interventions are being tested in trial NCT05445869?
The interventions under investigation include: ProSomnus® EVO Sleep and Snore Device (DEVICE).
Who is sponsoring clinical trial NCT05445869?
This trial is sponsored by ProSomnus Sleep Technologies, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.